SB
VRTX icon

SIG Brokerage’s Vertex Pharmaceuticals VRTX Stock Holding History

SIG Brokerage’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.86M Sell
17,605
-3,259
-16% -$1.52M 0.21% 92
2025
Q4 		$9.46M Sell
20,864
-5,526
-21% -$2.38M 0.29% 67
2025
Q3 		$10.3M Sell
26,390
-6,176
-19% -$2.58M 0.3% 61
2025
Q2 		$14.5M Buy
32,566
+31,446
+2,808% +$14.5M 0.38% 41
2025
Q1 		$543K Sell
1,120
-818
-42% -$381K 0.03% 346
2024
Q4 		$780K Buy
+1,938
New +$898K 0.04% 267

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

SIG Brokerage's VRTX Position: Q1 2026 in Review

SIG Brokerage reduced its Vertex Pharmaceuticals (VRTX) stake by 16% in Q1 2026, selling an estimated $1.52M and leaving 17,605 shares worth $7.86M. The position accounts for 0.21% of the portfolio, ranked #92.

SIG Brokerage first reported a position in VRTX in Q4 2024 and has held it in 6 quarters since. The position peaked at $14.5M in Q2 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • SIG Brokerage held 17,605 shares of Vertex Pharmaceuticals worth $7.86M as of Q1 2026.
  • SIG Brokerage sold 3,259 Vertex Pharmaceuticals shares in Q1 2026, an estimated $1.52M.
  • Vertex Pharmaceuticals made up 0.21% of SIG Brokerage's portfolio in Q1 2026, its #92 holding.
  • SIG Brokerage first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • SIG Brokerage's Vertex Pharmaceuticals position peaked at $14.5M in Q2 2025.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on SIG Brokerage's 13F filing for Q1 2026, filed 15 May 2026.